ZAMBELLI, STEFANIA
 Distribuzione geografica
Continente #
EU - Europa 328
NA - Nord America 205
AS - Asia 191
SA - Sud America 20
AF - Africa 2
Totale 746
Nazione #
US - Stati Uniti d'America 191
RU - Federazione Russa 175
IT - Italia 95
CN - Cina 70
SG - Singapore 61
HK - Hong Kong 18
BD - Bangladesh 15
BR - Brasile 15
VN - Vietnam 15
DE - Germania 11
FI - Finlandia 11
GB - Regno Unito 11
CA - Canada 9
NL - Olanda 7
FR - Francia 6
IN - India 4
PL - Polonia 4
SE - Svezia 4
AR - Argentina 2
MX - Messico 2
ZA - Sudafrica 2
AT - Austria 1
CH - Svizzera 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
PR - Porto Rico 1
PY - Paraguay 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 746
Città #
Singapore 36
Moscow 34
Ashburn 25
San Jose 25
Milan 20
New York 20
Hong Kong 18
Shanghai 13
Beijing 10
Dallas 9
Los Angeles 9
Boardman 8
Ho Chi Minh City 7
Council Bluffs 6
Hefei 6
Helsinki 6
Rome 6
Santa Clara 6
Lappeenranta 5
Lauterbourg 5
Poplar 5
Denver 4
Hanoi 4
Warsaw 4
Cesano Boscone 3
Chennai 3
Cornaredo 3
Costa de' Nobili 3
Montreal 3
Nuremberg 3
Orem 3
São Paulo 3
Amsterdam 2
Atlanta 2
Bari 2
Cagliari 2
Falkenstein 2
Fucecchio 2
Guangzhou 2
Jacksonville 2
Johannesburg 2
Livorno 2
Manchester 2
Naples 2
Perego 2
Phoenix 2
Pisa 2
Stezzano 2
Toronto 2
Vĩnh Long 2
Alcamo 1
Amman 1
Annapolis 1
Arezzo 1
Asunción 1
Bandaragama 1
Bangkok 1
Bologna 1
Boston 1
Brooklyn 1
Budapest 1
Buffalo 1
Byblos 1
Caldogno 1
Cardito 1
Changsha 1
Chicago 1
City of London 1
Clarksburg 1
Cleveland 1
Clorinda 1
Coruripe 1
Curitiba 1
Dhaka 1
Esperança 1
Extrema 1
Ferraz de Vasconcelos 1
Figino 1
Fredericton 1
Geneva 1
Georgetown 1
Greely 1
Guatemala City 1
Hoshiārpur 1
Houston 1
Jiaxing 1
Kassel 1
Kuala Lumpur 1
La Spezia 1
Lanham 1
Lanzhou 1
Lawrence 1
Llavallol 1
London 1
Melbourne 1
Messina 1
Mexico City 1
Motta Sant'Anastasia 1
Nashville 1
Nova Hartz 1
Totale 401
Nome #
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice 158
Spatial predictors of immunotherapy response in triple-negative breast cancer 147
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study 101
Modulation of the estrogen/erbB2 receptors crosstalk by CDK4/6 inhibition triggers sustained senescence in estrogen receptor and erbB2 positive breast cancer 95
Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers 92
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer 84
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies 49
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 29
Development and validation of a gene expression-based Breast Cancer Purity Score 15
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice 3
Totale 773
Categoria #
all - tutte 3.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 1 1 0 0
2022/20238 2 2 0 0 0 0 0 1 0 0 0 3
2023/202425 0 0 3 3 1 0 0 1 0 2 4 11
2024/2025168 21 11 4 11 19 17 20 31 7 4 7 16
2025/2026570 27 22 9 63 61 26 53 51 167 32 16 43
Totale 773